Clinical trial
Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients…
NCT00458809 · Wake Forest University Health Sciences, Other · Completed
Key facts
| NCT number | NCT00458809 |
|---|---|
| Title | Intraperitoneal Hyperthermic Perfusion With Oxaliplatin in Treating Patients With Stage IV Peritoneal Cancer Due to Appendix Cancer or Colorectal Cancer |
| Official title | A Phase I Evaluation of Intraperitoneal Hyperthermic Chemoperfusion With Oxaliplatin for Peritoneal Surface Disemmination of Appendiceal and Colorectal Cancer |
| Lead sponsor | Wake Forest University Health Sciences, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Carcinoma of the Appendix, Colorectal Cancer, Primary Peritoneal Cavity Cancer |
| Intervention type | Drug |
| Interventions | oxaliplatin |
| Enrollment | 16 |
| Start date | Mar 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Apr 11, 2007 |
| Last update posted | Aug 9, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: